Keyword: NIAID

If the German contract manufacturer delivers all projects over the 10-year course, it could receive up to $80 million.

Through an ongoing "challenge" study, FluGen hopes to see whether the nasal vaccine can fight off the flu virus that doesn't match its own.

Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.

Here is some other vaccine news of note for the week.

Johnson & Johnson's "mosaic" HIV vaccine regimen elicited immune responses one year after the final shot.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

Inovio's HIV vaccine is in early-stage development, but the company reported immune responses induced by the shot that lasted at least six months.

BiondVax enrolled its first patient in a phase 2 U.S. study of its universal flu vaccine, which aims to fight off all strains of the virus at the same time.